Role of vascular endothelial growth factor in hypoxia and monocrotaline induced pulmonary hypertension.

被引：0
|
作者：
Tuder, RM [1 ]
Allard, J [1 ]
Voelkel, NF [1 ]
机构：
[1] UNIV COLORADO,HLTH SCI CTR,DENVER,CO
来源：
CIRCULATION | 1996年 / 94卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3782 / 3782
页数：1
相关论文
共 50 条
  • [21] The effect of CP-96345 on the monocrotaline-induced pulmonary hypertension.
    Mathew, R
    Yuan, N
    Gewitz, M
    FASEB JOURNAL, 1999, 13 (05): : A827 - A827
  • [22] INCREASED HEPATOCYTE GROWTH FACTOR IN MONOCROTALINE-INDUCED PULMONARY HYPERTENSION IN RATS
    Radik, M.
    Kmecova, Z.
    Veteskova, J.
    Malikova, E.
    Krenek, P.
    Klimas, J.
    JOURNAL OF HYPERTENSION, 2018, 36 : E21 - E21
  • [23] Dipyridamole attenuates hypoxia-induced pulmonary hypertension.
    Ziegler, JW
    Ivy, DD
    Kinsella, JP
    Wiggins, JW
    Abman, SH
    PEDIATRIC RESEARCH, 1996, 39 (04) : 227 - 227
  • [24] Role of HIF-1β in endothelial cells in monocrotaline-induced pulmonary hypertension
    Fukuhara, Yayoi
    Tomita, Shuhei
    Urata, Masahisa
    Kihira, Yoshitaka
    Takaku, Mitsuru
    Ishizawa, Keisuke
    Ikeda, Yasumasa
    Tsuchiya, Koichiro
    Tamaki, Toshiaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 208P - 208P
  • [25] Raised levels of vascular endothelial growth factor and its soluble receptor in patients with hypertension.
    Belgore, F
    Lip, G
    Li-Saw-Hee, F
    Beevers, D
    Blann, A
    JOURNAL OF HYPERTENSION, 2000, 18 : S13 - S13
  • [26] Vascular Endothelial Growth Factor and ventricular remodeling in patients with type 2 diabetes and hypertension.
    Cipriani, R
    Iacobellis, G
    Gabriele, A
    Bianchi, C
    Pantellini, F
    Di Mario, U
    Morano, S
    DIABETOLOGIA, 2001, 44 : A306 - A306
  • [27] Assessment of the Endothelial Functions in Monocrotaline-induced Pulmonary Hypertension
    Sirmagul, Basar
    Ilgin, Sinem
    Atli, Ozlem
    Usanmaz, Suzan Emel
    Demirel-Yilmaz, Emine
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2013, 35 (03) : 220 - 227
  • [28] Growth factor expression and effects of amrinone in monocrotaline-induced pulmonary hypertension in rats
    Burch, GH
    Jensen, LR
    Pappas, J
    Hammond, EH
    Banner, W
    Shaddy, RE
    BIOCHEMICAL AND MOLECULAR MEDICINE, 1996, 58 (02) : 204 - 210
  • [29] Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis
    Murray, Lynne A.
    Habiel, David M.
    Hohmann, Miriam
    Camelo, Ana
    Shang, Huilan
    Zhou, Yang
    Coelho, Ana Lucia
    Peng, Xueyan
    Gulati, Mridu
    Crestani, Bruno
    Sleeman, Matthew A.
    Mustelin, Tomas
    Moore, Meagan W.
    Ryu, Changwan
    Osafo-Addo, Awo D.
    Elias, Jack A.
    Lee, Chun G.
    Hu, Buqu
    Herazo-Maya, Jose D.
    Knight, Darryl A.
    Hogaboam, Cory M.
    Herzog, Erica L.
    JCI INSIGHT, 2017, 2 (16):
  • [30] POLYAMINES AND EPIDERMAL GROWTH-FACTOR IN MONOCROTALINE-INDUCED PULMONARY-HYPERTENSION
    GILLESPIE, MN
    RIPPETOE, PE
    HAVEN, CA
    SHIAO, RT
    ORLINSKA, U
    MALEY, BE
    OLSON, JW
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (05): : 1463 - 1466
12345